πŸ‡ΊπŸ‡Έ FDA
Patent

US 10618908

Oxabicycloheptane prodrugs

granted A61KA61K31/337A61K31/34

Quick answer

US patent 10618908 (Oxabicycloheptane prodrugs) held by Lixte Biotechnology, Inc. expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/337, A61K31/34, A61K31/496, A61K45/06